Healix Health has partnered with Further to launch a new cancer care service for the workplace.
The Precision Cancer Service extends Helix’s current cancer care pathway by combining advanced genomic testing with expert clinical support.
Healix says this Precision medicine has been shown to reduce misdiagnosis risk by up to 38 per cent and treatment costs by around 35 per cent cost, helping deliver savings for employers. It can also improve survival rates.
It points out that cancer now accounts for around 30 per cent of private claims, compared with just 1 per cent 20 years ago.
This new service is offered for a fixed annual fee per principal member (including spouse and dependents) and available to employees diagnosed with stage 3 or 4 cancer, rare cancers, cancers of unknown primary and cancers that haven’t responded to first-line treatment.
The service is activated by the Healix clinical team, who coordinate access for eligible patients.
Advanced genomic testing is then carried out by Further, with results reviewed by an panel of international experts. These specialists develop a personalised treatment plan that incorporates relevant clinical trials and any hereditary considerations.
Patients receive their results in a consultation with a Further clinical case manager, who provides clear guidance, supports clinical trial enrolment where appropriate, and offers access to a dedicated genetics pathway for cancers with hereditary features.
Alongside this, a Healix nurse will provide ongoing support.
Healix Health CEO Ian Talbot said: “Cancer touches every organisation. It’s no longer rare; it’s a reality for any modern workforce, with nearly a third of private healthcare claims costs now related to cancer.
“While advances in treatment have improved survival rates, they have also introduced new complexities, rising costs and greater expectations.
“This new service is going to make a big difference to the way employers tackle cancer. By combining advanced testing with expert nurse support, the service helps deliver better outcomes for employees, strong engagement and productivity for businesses, and sustainable cost control for employers, while providing compassionate, world-class care at every level.”
